- CGON Dashboard
- Filings
- Insider
- Institutional
- Shorts
-
Article
Morgan Stanley Initiates Coverage On CG Oncology with Overweight Rating, Announces Price Target of $55
Company Profile
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.